References
- ALETAHA D, NEOGİ T, SİLMAN AJ, FUNOVİTS J, FELSON DT, BİNGHAM III CO, ET AL. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9): 2569-2581.
- GRAVALLESE EM, FİRESTEİN GS. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med. 2023;388(6):529-542.
- SCHERER HU, HAUPL T, BURMESTER GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110: 102400.
- YANG J, LI Q. Rheumatoid Arthritis. N Engl J Med. 2023;388(20):1919.
- ALIVERNINI S, FIRESTEIN GS, McINNES IB. The pathogenesis of rheumatoid arthritis. Immunity. 2022;55(12):2255-2270.
- YUAN S, LARSSON SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.
- VOGELE D, OTTO S, SOLLMANN N, HAGGENMÜLLER B, WOLF D, BEER M, SCHMİDT SA. Sarcopenia - Definition, Radiological Diagnosis, Clinical Significance. Rofo. 2023;195(5):393-405.
- CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, BOİRİE Y, CEDERHOLM T, LANDİ F, ET AL. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-423.
- WU D, LUO Y, LI T, ZHAO X, LV T, FANG G, et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022 Dec 22;13:1051082.
- BANO G, TREVİSAN C, CARRARO S, ET AL. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15.
- RALL LC, ROUBENOFF R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions Rheumatology. 2004; 43(10): 1219-23.
- NGEULEU A, ALLALİ F, MEDRARE L, MADHİ A, RKAİN H, HAJJAJ-HASSOUNİ N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017; 37(6): 1015-1020.
- BAHAT G, TUFAN A, TUFAN F, KİLİC C, AKPİNAR TS, KOSE M, ET AL. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35(6): 1557-63.
- ROBERTS HC, DENİSON HJ, MARTİN HJ, PATEL HP, SYDDALL H, COOPER C, SAYER AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011; 40(4): 423-9
- TRUDELLE-JACKSON E, JACKSON AW, FRANKOWSKİ CM, LONG KM, MESKE NB. Interdevice Reliability and Validity Assessment Of The Nicholas Hand-Held Dynamometer. J Orthop Sports Phys Ther. 1994; 20: 302-6.
- FRİES JF, SPİTZ PW, YOUNG DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789-93.
- VLAEYEN JWS, KOLE-SNİJDERS AMJ, ROTTEVEEL AM, ET AL. The role of fear of movement/(re)injury in pain disability. J Occup Rehab. 1995; 5(4): 235-252.
- KUMBAROĞLU FB, KARAKAYA KARABULUT J, APRAŞ BİLGEN Ş, ÜNAL E. Determination of the validity, reliability, and sensitivity of the BETY- Biopsychosocial Questionnaire in patients with a diagnosis of rheumatoid arthritis. JETR. 2021; 8(1): 90-98.
- WARE JE JR, SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30 (6): 473-83.
- TEKGOZ E, COLAK S, OZALP ATES FS, SONAEREN I, YİLMAZ S, CİNAR M. Sarcopenia in rheumatoid arthritis: Is it a common manifestation? Int J Rheum Dis. 2020; 23(12): 1685–1691.
- AMİNOV K. Sarcopenia and osteoporosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2017; 76: 1351
- REİNA D, GÓMEZ-VAQUERO C, DÍAZ-TORNÉ C, SOLÉ JMN. Assessment of nutritional status by dual X-Ray absorptiometry in women with rheumatoid arthritis: A case-control study. Medicine (Baltimore). 2019; 98(6): e14361.
- DAO HH, DO QT, SAKAMOTO J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology. 2011; 50(7): 1250-8.
- DOĞAN SC, HİZMETLİ S, HAYTA E, KAPTANOĞLU E, ERSELCAN T, GÜLER E. Sarcopenia in women with rheumathoid arthritis. Eur J Rheumatol. 2015; 2(2): 57–61.
- ALKAN-MELİKOĞLU M. Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Arch Rheumatol. 2017; 32(1): 53-59.
- TADA M, YAMADA Y, MANDAİ K, HİDAKA N. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis-results from the CHIKARA study. Int J Rheum Dis. 2018; 21(11): 1962-1969.
- KEEFE FJ, SMİTH SJ, BUFFİNGTON AL, ET AL. Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis. J Consult Clin Psychol. 2002; 70(3): 640-655.
- UHLİG T, LOGE JH, KRİSTİANSEN IS, ET AL. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007; 34(6): 1241-1247.
- LEE MK, JEONG HH, KİM MJ, RYU H, BAEK J, LEE B. Nutrients against Glucocorticoid-Induced Muscle Atrophy. Foods. 2022;11(5):687.
- HEIN TR, PETERSON L, BARTIKOSKI BJ, PORTES J, ESPIRITO SANTO RC, XAVIER RM. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Res Ther. 2022;24(1):171.
- YAMADA Y, TADA M, MANDAI K. HIDAKA N, INUI K, NAKAMURA H. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin Rheumatol. 2020;39:1757–1764.
- MOSCHOU D, KRIKELIS M, GEORGAKOPOULOS C, MOLE E, CHRONOPOULOS E, TOURNIS S, et al. Sarcopenia in Rheumatoid arthritis. A narrative review. J Frailty Sarcopenia Falls. 2023;8(1):44-52.